{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:25:21Z","timestamp":1793849121842,"version":"4.6.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020098","name":"Innovative Health Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clinthera.2026.07.015","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:20:58Z","timestamp":1787390458000},"page":"1056-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early Feasibility Studies for Medical Devices: Insights From an Empirical Global Mapping"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8810-0211","authenticated-orcid":false,"given":"Franco Luigi","family":"Zurlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Buzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Banks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Callea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.07.015_bib0001","unstructured":"International Organization for Standardization. ISO 14155:2026 Clinical investigation of medical devices for human subjects \u2013 good clinical practice. https:\/\/www.iso.org\/standard\/83968.html (accessed July 10, 2024)."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0002","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacbts.2016.06.003","article-title":"Drugs and devices: comparison of European and U.S. approval processes","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0003","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jacbts.2016.03.009","article-title":"Drugs, devices, and the FDA: Part 2: an overview of approval processes: FDA approval of medical devices","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0004","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.neurom.2023.04.472","article-title":"Regulatory framework for implantable neurostimulation devices: comparison of systems in the US and European Union","volume":"27","author":"Amon","year":"2024","journal-title":"Neuromodulation: Technol Neural Interface"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0005","unstructured":"FDA Center for Devices and Radiological. Regulatory controls. FDA. 2023. https:\/\/www.fda.gov\/medical-devices\/overview-device-regulation\/regulatory-controls (accessed July 4, 2025)."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0006","first-page":"626","article-title":"Clinical perspective \u2013 early feasibility device medical studies in the United States: time for more than regulatory reform","volume":"9","author":"Holmes","year":"2016","journal-title":"JACC: Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0007","unstructured":"Consortium MDI. Early feasibility studies program. MDIC Medical Device Innovation Consortium. 2024. https:\/\/mdic.org\/program\/early-feasibility-studies-efs\/ (accessed June 18, 2024)."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0008","unstructured":"FDA Center for Devices and Radiological. Early feasibility studies (EFS) program. FDA. 2023; https:\/\/www.fda.gov\/medical-devices\/investigational-device-exemption-ide\/early-feasibility-studies-efs-program (accessed July 4, 2025)."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0009","unstructured":"FDA. Investigational device exemptions (IDEs) for early feasibility medical device clinical studies, including certain first in human (FIH) studies. 2013. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/investigational-device-exemptions-ides-early-feasibility-medical-device-clinical-studies-including (accessed June 19, 2024)."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0010","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2016.07.769","article-title":"Overcoming the challenges of conducting early feasibility studies of medical devices in the United States","volume":"68","author":"Holmes","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0011","unstructured":"Regulation (EU) 2017\/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and repealing Council Directives 90\/385\/EEC and 93\/42\/EEC (Text with EEA relevance). 2017 http:\/\/data.europa.eu\/eli\/reg\/2017\/745\/oj\/eng (accessed Oct 29, 2024)."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0012","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jse.2024.08.011","article-title":"European medical devices regulation: a plea for ensuring safety without slowing access to innovation","volume":"34","author":"Pe\u00f1arrubia-Ortiz","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17434440.2022.2075729","article-title":"Recommendations for the design and implementation of an early feasibility studies program for medical devices in the European Union","volume":"19","author":"Callea","year":"2022","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.clinthera.2026.07.015_bib23","unstructured":"World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), 2019 version. Geneva: World Health Organization; 2019. https:\/\/icd.who.int\/browse10\/2019\/en."},{"key":"10.1016\/j.clinthera.2026.07.015_bib0014","first-page":"1784","article-title":"Regulatory strategies for early device development and approval","volume":"99","author":"Holmes","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2026.06.003","article-title":"Early feasibility studies in Europe: a multisite qualitative study of operational challenges and site selection determinants at 6 university hospital","author":"Valledor","year":"2026","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0016","first-page":"1","article-title":"Pre-market clinical investigation approval pathways and the role of early feasibility studies for medical devices: a scoping review to guide EU policy","volume":"25","author":"Banks","year":"2026","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/17434440.2023.2192868","article-title":"An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations","volume":"20","author":"Tarricone","year":"2023","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0018","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/eurheartj\/ehaf069","article-title":"Priorities for medical device regulatory approval: a report from the European Society of Cardiology Cardiovascular Round Table","volume":"46","author":"Windecker","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0019","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s43441-024-00632-7","article-title":"EU\u2019s medical device expert panels: analysis of membership and published clinical evaluation consultation procedure (CECP) results","volume":"58","author":"Watson","year":"2024","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0020","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/jce.15869","article-title":"Early feasibility studies in the United States: focus on electrophysiology","volume":"34","author":"Weiss","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR Guiding Principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Sci Data"},{"key":"10.1016\/j.clinthera.2026.07.015_bib0022","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(04)17034-7","article-title":"Clinical trial registration: a statement from the International Committee of Medical Journal Editors","volume":"364","author":"De Angelis","year":"2004","journal-title":"Lancet"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826002766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:36:27Z","timestamp":1793846187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826002766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0149291826002766"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Feasibility Studies for Medical Devices: Insights From an Empirical Global Mapping","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}